Gordon Winston Kinder - 14 Mar 2022 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Role
Chief Financial Officer
Signature
/s/ Gordon Kinder
Issuer symbol
BJDX
Transactions as of
14 Mar 2022
Net transactions value
+$15,530
Form type
4
Filing time
16 Mar 2022, 21:54:31 UTC
Previous filing
28 Feb 2022
Next filing
21 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BJDX Common Stock Purchase $9,975 +10,500 $0.9500 10,500 14 Mar 2022 Direct F1
transaction BJDX Common Stock Purchase $455 +500 +4.8% $0.9100 11,000 15 Mar 2022 Direct
transaction BJDX Common Stock Purchase $5,100 +5,000 +45% $1.02 16,000 16 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $0.90 to $0.95. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $1.01 to $1.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.